DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

DIGITAL CONTENT

3 NEWS #PharmaBuzz

media
3 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

5DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Kin-2787 free base, 2vpx8hl8ab, Exarafenib [inn], Unii-2vpx8hl8ab, Schembl23275448, Gtpl12095

Molecular Formula

C₂₆H₃₄F₃N₅O₃

Molecular Weight

521.6 g/mol

InChI Key

GZMYLSJUNSCMTD-MOPGFXCFSA-N

FDA UNII

2VPX8HL8AB

1 2D Structure

Exarafenib

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(3S)-N-[3-[2-[[(2R)-1-hydroxypropan-2-yl]amino]-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide

2.1.2 InChI

InChI=1S/C26H34F3N5O3/c1-17-3-4-21(31-25(36)34-6-5-19(15-34)14-26(27,28)29)13-22(17)20-11-23(30-18(2)16-35)32-24(12-20)33-7-9-37-10-8-33/h3-4,11-13,18-19,35H,5-10,14-16H2,1-2H3,(H,30,32)(H,31,36)/t18-,19+/m1/s1

2.1.3 InChI Key

GZMYLSJUNSCMTD-MOPGFXCFSA-N

2.1.4 Canonical SMILES

CC1=C(C=C(C=C1)NC(=O)N2CCC(C2)CC(F)(F)F)C3=CC(=NC(=C3)N4CCOCC4)NC(C)CO

2.1.5 Isomeric SMILES

CC1=C(C=C(C=C1)NC(=O)N2CC[C@H](C2)CC(F)(F)F)C3=CC(=NC(=C3)N4CCOCC4)N[C@H](C)CO

2.2 Other Identifiers

2.2.1 UNII

2VPX8HL8AB

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Kin-2787 Free Base

2. 2vpx8hl8ab

3. Exarafenib [inn]

4. Unii-2vpx8hl8ab

5. Schembl23275448

6. Gtpl12095

7. Bdbm514652

8. Us11098031, Example 14

9. Example 14 [wo2021081375a1]

10. Hy-147268

11. Cs-0542473

12. (3s)-n-(3-(2-(((2r)-1-hydroxypropan-2-yl)amino)-6- (morpholin-4-yl)pyridin-4-yl)-4-methylphenyl)-3-(2,2,2- Trifluoroethyl)pyrrolidine-1-carboxamide

13. (3s)-n-[3-[2-[[(2r)-1-hydroxypropan-2-yl]amino]-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide

14. (s)-n-(3-(2-(((r)-1-hydroxypropan-2- Yl)amino)-6-morpholinopyridin-4-yl)-4- Methylphenyl)-3-(2,2,2- Trifluoroethyl)pyrrolidine-1-carboxamide

15. 1-pyrrolidinecarboxamide, N-(3-(2-(((1r)-2-hydroxy-1-methylethyl)amino)-6-(4-morpholinyl)-4-pyridinyl)-4-methylphenyl)-3-(2,2,2-trifluoroethyl)-, (3s)-

16. 2639957-39-2

2.4 Create Date

2021-08-21

3 Chemical and Physical Properties

Molecular Formula	C₂₆H₃₄F₃N₅O₃
Molecular Weight	521.6 g/mol
XLogP3	4
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	7
Exact Mass	521.26137445 g/mol
Monoisotopic Mass	521.26137445 g/mol
Topological Polar Surface Area	90 Å²
Heavy Atom Count	37
Formal Charge	0
Complexity	739
Isotope Atom Count	0
Defined Atom Stereocenter Count	2
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1